Search research articles
Contact Us
Filters
Showing results (11-20 of 25) with videos related to
Page
of 3
Sort By:
American Journal of Hypertension
|
July 13, 2012
Regorafenib induces rapid and reversible changes in plasma nitric oxide and endothelin-1
Nilka de Jesus-Gonzalez, Emily Robinson, Radostin Penchev, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 17, 2003
Crossover randomized comparison of intravenous versus intravenous/oral mesna in soft tissue sarcoma treated with high-dose ifosfamide
Joseph R Mace, Mary L Keohan, Heinz Bernardy, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 4, 2020
A phase II multi-strata study of lurbinectedin as a single agent or in combination with conventional chemotherapy in metastatic and/or unresectable sarcomas
Gregory M Cote, Edwin Choy, Tianqi Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 18, 2012
Phase II study of ganitumab, a fully human anti-type-1 insulin-like growth factor receptor antibody, in patients with metastatic Ewing family tumors or desmoplastic small round cell tumors
William D Tap, George Demetri, Phillip Barnette, et al.
Cancer Research
|
October 30, 2010
The neuroblastoma-associated F1174L ALK mutation causes resistance to an ALK kinase inhibitor in ALK-translocated cancers
Takaaki Sasaki, Katsuhiro Okuda, Wei Zheng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 4, 2008
CpG oligodeoxynucleotides alter lymphocyte and dendritic cell trafficking in humans
W Nicholas Haining, Jeffrey Davies, Holger Kanzler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 18, 2008
Regression of drug-resistant lung cancer by the combination of rosiglitazone and carboplatin
Geoffrey D Girnun, Liang Chen, Jessica Silvaggi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 2, 2026
A Phase 2 Study of the Eribulin in Patients with Metastatic Angiosarcoma and Epithelioid Hemangioendothelioma (EHE)
Gregory M Cote, Mason Aberoumand, Edwin Choy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 24, 2008
Clinical cancer advances 2008: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology
Eric Winer, Julie Gralow, Lisa Diller, et al.
Future Oncology (London, England)
|
February 11, 2025
SaLudo: a randomized phase IIb/III study of lurbinectedin plus doxorubicin as first-line treatment in leiomyosarcoma
Gregory M Cote, Sant P Chawla, George Demetri, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 25) with videos related to
Sort By:
Page
of 3
American Journal of Hypertension
|
July 13, 2012
Regorafenib induces rapid and reversible changes in plasma nitric oxide and endothelin-1
Nilka de Jesus-Gonzalez, Emily Robinson, Radostin Penchev, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 17, 2003
Crossover randomized comparison of intravenous versus intravenous/oral mesna in soft tissue sarcoma treated with high-dose ifosfamide
Joseph R Mace, Mary L Keohan, Heinz Bernardy, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 4, 2020
A phase II multi-strata study of lurbinectedin as a single agent or in combination with conventional chemotherapy in metastatic and/or unresectable sarcomas
Gregory M Cote, Edwin Choy, Tianqi Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 18, 2012
Phase II study of ganitumab, a fully human anti-type-1 insulin-like growth factor receptor antibody, in patients with metastatic Ewing family tumors or desmoplastic small round cell tumors
William D Tap, George Demetri, Phillip Barnette, et al.
Cancer Research
|
October 30, 2010
The neuroblastoma-associated F1174L ALK mutation causes resistance to an ALK kinase inhibitor in ALK-translocated cancers
Takaaki Sasaki, Katsuhiro Okuda, Wei Zheng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 4, 2008
CpG oligodeoxynucleotides alter lymphocyte and dendritic cell trafficking in humans
W Nicholas Haining, Jeffrey Davies, Holger Kanzler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 18, 2008
Regression of drug-resistant lung cancer by the combination of rosiglitazone and carboplatin
Geoffrey D Girnun, Liang Chen, Jessica Silvaggi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 2, 2026
A Phase 2 Study of the Eribulin in Patients with Metastatic Angiosarcoma and Epithelioid Hemangioendothelioma (EHE)
Gregory M Cote, Mason Aberoumand, Edwin Choy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 24, 2008
Clinical cancer advances 2008: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology
Eric Winer, Julie Gralow, Lisa Diller, et al.
Future Oncology (London, England)
|
February 11, 2025
SaLudo: a randomized phase IIb/III study of lurbinectedin plus doxorubicin as first-line treatment in leiomyosarcoma
Gregory M Cote, Sant P Chawla, George Demetri, et al.
Page
of 3